Daniel Alos-Gil
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Case Report: Durable remission of intraocular mantle cell lymphoma after CD19 CAR-T therapy.
Journal: Frontiers in immunology
Published: January 12, 2026
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies.
Journal: Journal for immunotherapy of cancer
Published: November 25, 2025
Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMD.
Journal: Frontiers in immunology
Published: November 10, 2025
Mass Spectrometry Profiling of Therapeutic Antibodies in Multiple Myeloma: m/z Features and Concordance with Immunofixation Electrophoresis.
Journal: Biomedicines
Published: October 16, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells.
Journal: Blood
Published: May 28, 2024
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.
Journal: bioRxiv : the preprint server for biology
Published: March 11, 2024
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Journal: Frontiers in immunology
Published: December 04, 2023
Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network.
Journal: Blood cancer journal
Published: March 29, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026